PAULIANNE CZESCA GONZALES: Open Payments
NPI 1679083471 · DOWNERS GROVE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$308 in 16 payments from 10 companies in 2025. Trend: 2023 $25 · 2024 $81 · 2025 $308
Food & beverage: $308
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 4 | $78 |
| PFIZER INC. | 2 | $46 |
| ABBVIE INC. | 2 | $40 |
| Novo Nordisk Inc | 2 | $31 |
| Amgen Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Noven Therapeutics, LLC | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Neos Therapeutics, LP | 1 | $14 |
Products named: REXULTI, NURTEC ODT, VRAYLAR, REPATHA, CAPLYTA, Xelstrym, TRINTELLIX, Adzenys XR-ODT.
Industry payments across IL — which companies pay providers there.
